Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (17)

2024

  1. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family

    Cancer Communications

  2. Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting

    Thrombosis Research, Vol. 240

  3. The T-cell repertoire of Spanish patients with COVID-19 as a strategy to link T-cell characteristics to the severity of the disease

    Human Genomics, Vol. 18, Núm. 1

2023

  1. Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity

    Human Genomics, Vol. 17, Núm. 1

2022

  1. Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival

    Viruses, Vol. 14, Núm. 9

  2. Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

    Pharmaceutics, Vol. 14, Núm. 8

  3. Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19

    Frontiers in Immunology, Vol. 13

2021

  1. Genetic polymorphisms affecting ranibizumab response in high myopia patients

    Pharmaceutics, Vol. 13, Núm. 11

  2. Pharmacogenetic polymorphisms affecting bisoprolol response

    Biomedicine and Pharmacotherapy, Vol. 142

2020

  1. Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis

    Genes, Vol. 11, Núm. 11, pp. 1-13

  2. Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy

    Cancers, Vol. 12, Núm. 2

2019

  1. Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention

    Pharmacogenomics Journal, Vol. 19, Núm. 5, pp. 438-445

  2. Pharmacogenetics in the Treatment of Cardiovascular Diseases and its current progress regarding Implementation in the Clinical Routine

    Genes, Vol. 10, Núm. 4

2017

  1. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population

    PLoS ONE, Vol. 11, Núm. 3

  2. Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty

    Pharmacogenomics, Vol. 17, Núm. 12, pp. 1327-1338

2015

  1. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: A meta-analysis

    Pharmacogenetics and Genomics, Vol. 25, Núm. 8, pp. 388-393